|
|
 |
History in the UKLooking back over time |
|
|
|
|
Baxter's IV containers have changed over time. Baxter International was the first commercial manufacturer of IV solutions in glass bottles. Forty years later Baxter introduced the first flexible plastic IV container and set a new standard for IV therapy that continues today.
|
|
|
|
|
- 1960: Baxter Laboratories expand into Europe and the UK business is created with an annual turnover of £208, 000
- 1960: Edwards Laboratories Ltd later to become a division of Baxter introduces the first implantable heart valve
- 1961: Baxter stock begins trading on the New York Stock Exchange
- 1962: Baxter introduces the first dispsable total bypass blood oxygenator making open heart surgey possible
- 1965: The Thetford manufacturing facility opens in November
- 1966: The first commercially produced factor VIII product for people with haemophilia is introduced
- 1967: Baxter produce the first peritoneal dialysis solution - only available in glass containers
- 1968: Phase 2 of building expansion started at Thetford for the production of Triflex - medical PVC gloves
- 1969: Fenwal blood packs are manufactured at Thetford as the workforce grows to 250 people
|
|
|
|
|
- 1970: The Viaflex plastic container is produced, revolutionising intravenous fluids. It is not unitl 1974 that Viaflex containers are manufatured in Britain
- 1976 : The final phase of theThetford site is built - this includes facilities for Polypropylene bottled packs and PVC manufacturing
- 1977: Nelson manufacturing site opens. The new facility at Nelson is built to produce administration sets
- 1975: 'Unicare' renal homecare service is introduced
- 1976: Baxter adopts the new name of Travenol Laboratries, a name it kept until 1986- 1978: Baxter launches CAPD (continuous ambulatory peritoneal dialysis) as a practical alternative to haemodialysis. CAPD was to revolutionise the treament of renal failure. In the UK, the launch was featured on Tomorrow's World
- 1979: The first automated blood cell separator the CS3000 system is introduced
|
|
|
|
|
- 1980: Sales and Marketing move to Egham in order to be closer to Heathrow and the Baxter export offices in Hayes. Annual Turnover hits £40, 518, 000
- 1981: Unicare is acquired to support the growing number of home dialysis patients
- 1982: Thetford compounding site opens incorporating state of the art isolating equipment-
- 1984: The Novacor left ventricular assist system (LVAS) is launched, helping to keep a human heart alive until a donor heart becomes available for transplant
- 1985: The Bangor site is the first of several renal units opened by Baxter's Renal Therapy Services (RTS)
- 1985: The first pharmacy compounding unit opened at Mount Vernon Hospital, another excellent joint venture with the NHS
- 1987: Ipswich RTS Unit opens
- 1988: The Compton office opens
- 1988: The new National Distribution Centre opens in Northampton
- 1989: Merthyr Tydfil and Cardiff RTS Units opens
|
|
|
|
|
- 1990: Baxter celebrates 25 years of manufacturing in Thetford with an open day attracting over 2000 people
- 1991: The first independent renal training centre opens in Wandsworth
- 1992: Baxter produces the world's first genetically manufactured recombinant factor VIII . This helps to reduce the risk of viral contamination for people with haemophilia
- 1992: Compton becomes the new UK Head Office as Egham closes
- 1994: Homechoice, the first portable dialysis machine for patients to use overnight at home is launched
- 1996: Baxter launches Amicus blood cell separator in the UK for collecting platelets and other blood components
- 1996: Baxter spins off Allegiance Corporation-
- 1998: Baxter acquires anaesthesia products from Pharmacia Upjohn and the Crowthorne Office is born-
- 1998: Newport RTS unit opens - further improving renal provision in Wales
- 1999: Unicare Renal homecare service celebrates its 25th Anniversary- 1999: Bristol RTS Unit opens. The first unit in a Government funded Health Park-
- 1999: Baxter UK ends the 20th century with a turnover of £247 million
|
|
|
|
|
- 2000: Baxter spins-off its CardioVascular Group as a separate, publicly traded entity under the name of Edwards Lifesciences
- 2000: Baxter is one of five leading healthcare companies to create the Global Healthcare Exchange, an independent, Internet based company that facilitates the exchnage of information related to buying, selling and distributing medical equipment, devices and healthcare products and services worldwide
- 2000: 40 year anniversary of Baxter Healthcare in the UK
- 2001: Launch of Baxter´s Oncology business-
- 2002: Launch of Viaflo non PVC IV containers-
- 2002: Launch of Homechoice Pro for Paediatric patients
- 2002: Baxter completes acquistion of Fusion Medical Technologies
- 2003: Baxter introduces in the United States the first recombinant factor VIII with no added human or animal proteins in the cell culture process, purification and final formulation
- 2004: Baxter introduces into Europe the first recombinant factor VIII with no added human or animal proteins in the cell culture process, purification and final formulation
|
|
|
|
|
|
|
|
|
|
|
Print this page
